BioGaia® Gastrus
Unique Evidence-Based Probiotic Combination
BioGaia® Gastrus contains Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475, sourced from human origin.
Dosage: Adults: Consume 1 chewable tablet daily, with meals, or as directed by your healthcare professional.
Each BioGaia® Gastrus chewable tablet contains:
|
Lactobacillus reuteri (DSM 17938) |
350 mg (100 million organisms) |
|
Lactobacillus reuteri (ATCC PTA 6475) |
350 mg (100 million organisms) |
- Does not require refrigeration, for ease of use and convenience.
- Contains only probiotic strains of human origin: Lactobacillus reuteri DSM 17938 + Lactobacillus reuteri ATCC PTA 6475 (both strains isolated from breast milk)
- Provides evidence-based probiotic strains with clinical data to support their use
- Delivers probiotic strains that survive transit through gastrointestinal (GI) tract without significant loss of potency (CFUs)
- Contains two probiotic strains shown to colonise the GI tract and adhere strongly to mucosal layer
- Ensure only complementary probiotic strains are combined for optimal efficacy
- Delivers a scientifically validated daily dose of 200 million organisms (CFUs) in a convenient one-a-day dose